Realize the Promise of Multi-Omics for Precision Medicine
Marie-Ange Kouassi September 1, 2024
Product Characterization and Biosafety in GxP with NGS | Part 1
Valentina Armiento May 30, 2024
Product Characterization and Biosafety in GxP with NGS | Part 2
Validating NGS Assays in Light of Regulatory Changes
Urszula Cendrowska April 22, 2024
NGS-Based Assays for CGT Development
Marie-Ange Kouassi February 14, 2024
Harnessing the Power of Data in the Fight Against Cancer
Andrea Amantonico, Edgar Dawkins, Raed Hmadi, Marie-Ange Kouassi, Allison Kurz, Justyna Lisowska, Benjamin Thomas, Ada Yee February 4, 2024
NGS Revolution for Establishing CQAs of CGT Products
Marie-Ange Kouassi January 30, 2024
Accelerating CGT Product Development via NGS
Urszula Cendrowska November 15, 2023
The Power of NGS for Nanobody Discovery & Development
Raed Hmadi October 2, 2023
Knowledge Exchange to Accelerate Gene Therapy Product Development
Marie-Ange Kouassi June 29, 2023
Innovation Through Automation of Lab Data Analysis
Stephan Steigele June 16, 2023
Maximize Return on Your Lab Automation Investment
Sascha Fischer June 12, 2023
Cell Therapy: The Potential for Effective Precision Medicine
Nicholas S. Geraci & Justyna Lisowska June 7, 2023
Precision Medicine in Alzheimer’s Disease – The Time Is Now!
Justyna Lisowska May 9, 2023
NGS-Based Vector Integrity Confirmation for Gene Therapy Products
Marie-Ange Kouassi, Qiu Ruan, Marcell Veidner, Devon Ryan April 27, 2023
RNA Therapies on the Rise—and Data Challenges, Too
Ming Wang April 24, 2023
Unlocking the Power of Posit and R for Precision Medicine Development
Marie-Ange Kouassi & Hagen Klett February 27, 2023
R&D Digitalization: Industry Perspectives from the Open Forum at EMD Serono
Jana Hersch November 17, 2022
Genedata at Bio Japan 2022
Naho Shimoyama November 9, 2022
Uniting to Transform Biotherapeutic Product QC with NGS
Marie-Ange Kouassi October 30, 2022
Interview: Automated Screening for COVID-19 Drugs
Jasmin Lozza October 17, 2022
Modern AI Technologies for Label Free Live Cell Imaging
Cameron Scott, Ph.D. October 13, 2022
Comprehensive Viral Detection in Biologics Manufacturing
Marie-Ange Kouassi October 6, 2022
Collaboration and Digitalization Fuel Biopharma Innovation
Jana Hersch September 25, 2022
On the Path to Precision in Alzheimer’s Disease Management
Justyna Lisowska September 21, 2022
Foster Open Innovation for Cell Therapy Development
Justyna Lisowska July 19, 2022
Discussions on Optimizing Cell Line Development with NGS
Marie-Ange Kouassi July 18, 2022
Accelerated mAb Manufacturing: 3 Months to GMP
Marie-Ange Kouassi June 24, 2022
Advance Translational Research with a Powerful Data Inventory
Marie-Ange Kouassi June 9, 2022
Using TLA for Genomic Fingerprinting of Production Cell Lines
Marie-Ange Kouassi April 24, 2022
Leveraging a Data Strategy for Improved Clinical Success Rates
Lakshmi Maithel March 29, 2022
Unusual Biological Product Characteristic Identified with NGS
Marie-Ange Kouassi March 10, 2022
Fireside Discussions on NGS-Based Biosafety - A Gamechanger
Marie-Ange Kouassi February 8, 2022
World Cancer Day at Genedata
Jana Hersch, Marie-Ange Kouassi, Justyna Lisowska, Jason Smith, Ada Yee February 4, 2022
Facilitating Knowledge Exchange on NGS-Based Biosafety Testing
Marie-Ange Kouassi December 9, 2021
Going Beyond a Biomarker-Driven Strategy
Justyna Lisowska November 30, 2021
Screener User Community Comes Together
Jackie Thrasivoulos & Ada Yee October 13, 2021
Leveraging Data on the Journey to Successful Cell Therapy
Justyna Lisowska & Marie-Ange Kouassi September 29, 2021
Interview: Bispecific Development at Amgen
Ada Yee September 1, 2021
The Promises and Challenges of Cell Therapies
Marie-Ange Kouassi August 25, 2021
